Search filters

List of works by Giuliano Rizzardini

96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience

scientific article

A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy

scientific article published on 15 February 2013

An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents

scientific article published on 26 December 2018

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

article

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

scientific article

Cholesterol levels in HIV–HCV infected patients treated with lopinavir/r: Results from the SCOLTA project

article

Choosing appropriate pharmacotherapy for drug-resistant HIV

scientific article published on 24 January 2019

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

scientific article published on 20 September 2011

Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing

scientific article

Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study

scientific article published on February 2015

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World.

scientific article published on 3 January 2014

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

scientific article

Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world

scientific article

Determinants of bone diseases in tenofovir-treated HIV patients.

scientific article published on June 2016

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy

scientific article published on March 2016

Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV-infected patients with virological suppression

scientific article

Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment

scientific article published on 11 February 2019

Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting

scientific article published on 13 September 2013

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study

scientific article published on 10 August 2020

Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis

scientific article

Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF.

scientific article published on 25 September 2017

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

scientific article published on 3 March 2017

Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)

scientific article published on 14 August 2020

Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.

scientific article

Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals

scientific article published in April 2004

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

scientific article

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

scientific article published on 24 November 2014

How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life?

scientific article published on 20 January 2017

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders

scientific article published on 16 May 2011

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

scientific article published in August 2010

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

scientific article

Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS

article

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons

scientific article published on April 30, 2011

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

scientific article published on March 31, 2012

KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy

scientific article

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

scientific article published on April 2014

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections

scientific article published on 04 April 2013

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

scientific article (publication date: 2013)

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment

article

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

scientific article

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

scientific article

Negative Influence of HIV Infection on Day-Night Blood Pressure Variability

article

New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

scientific article published on 11 August 2015

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program

scientific article published on 22 December 2016

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

scientific article

Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV

scientific article published on 03 November 2019

Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients

scientific article published on 3 October 2014

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.

scientific article

Probiotics Reduce Gut Microbial Translocation and Improve Adult Atopic Dermatitis

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort

scientific article

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals

scientific article published on 5 May 2005

Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

scientific article published on 20 June 2012

Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study

scientific article published on 26 March 2020

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

scientific article published on 11 January 2012

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

scientific article

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection

scientific article published on June 30, 2012

The cost of HIV disease in Northern Italy: the payer's perspective

scientific article published in July 2011

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

scientific article

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort

scientific article

Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness

scientific article published on 12 December 2008

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study

scientific article

Paulina is supported by:

About Paulina

Help